Comparative Evaluation of Penicillin, Ampicillin, and Imipenem MICs and Susceptibility Breakpoints for Vancomycin-Susceptible and Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium
Although imipenem has in vitro activity against Enterococcus faecalis and Food and Drug Administration-approved indications for treatment of infections caused by this microorganism, there are no NCCLS guidelines for susceptibility testing of imipenem versus enterococci. Therefore, the in vitro activ...
Salvato in:
| Pubblicato in: | J Clin Microbiol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
2001
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC88224/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11427608/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.39.7.2729-2731.2001 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|